In peripheral blood, loss of CD26 (≥80% CD4+ T cells) and/or CD7 (≥40% CD4+ T cells) alongside other gene expression biomarkers such as STAT4, TWIST1, DNM3, and PLS3 aid in diagnosis of 83% and 98% of SS respectively (22). The gene discussed is CD4; the disease is synovial sarcoma.